TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer

Acta Oncologica

Volumn 39, Issue 3, 2000, Pages 327-333

  Overgaard, J ^a   Yilmaz, M ^a   Guldberg, P ^a   Hansen, L L ^a   Alsner, J ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN P53; TUMOR MARKER;

ADULT; AGE; AGED; ANAPLASTIC CARCINOMA; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 0033885192     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600750013096     Document Type: Conference Paper

References (24)

1. Postoperative radiotherapy in high-risk premenopausal breast patients given adjuvant systemic therapy. Report from the Danish Breast Cancer Cooperative Group DBCG 82b Trial
2. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen
3. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
4. Sentinel-lymph-node biopsy for breast cancernot yet the standard of care
5. Prognostic and predictive value of p53 and p21 in breast cancer
6. Determination and use of p53 in the management of cancer patients with special focus on breast cancer - A review
7. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
8. The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry
9. Relation of tumor size, lymph node status, and survival in 24 750 breast cancer cases
10. The link between local recurrence and distant metastases in human breast cancer
11. Prognostic variables in node-negative and node-positive breast cancereditorial
12. Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement
13. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer
14. Single-step DGGE-based mutation scanning of the p53 gene: Application to genetic diagnosis of colorectal cancer
15. Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1 400 node-negative breast cancers
16. Prognostic value of p53 gene mutations in a large series of node-negative breast cancer patients
17. The relationship between prognostic and predictive factors in the management of breast cancer
18. Methodological challenges in the evaluation of prognostic factors in breast cancer
19. The p53 status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: A novel hypothesis based on clinical findings
20. Subgroups of p53 mutations may predict the clinical behavior of cancers in the breast and colon and contribute to therapy response
21. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer
22. Assessing the clinical impact of prognostic factors: When is 'statistically significant' clinically useful?